GPX4 and acute myeloid leukemia: The transcriptional activator of p53, APR-246, alone and in combination with the GPX4 inhibitors RSL3 and FINO2, reduces the ability of AML clones to detoxify membrane lipid peroxidation, activating ferroptosis [151].